A new report reveals that delays in incident reporting and resolution are severely impacting productivity in Indian ...
Glenmark Pharmaceuticals reports a staggering 56.7% decline in net profit to ₹264 crore for Q2 FY27, with a 29.8% drop in ...
Dr Reddy’s Laboratories has received marketing approval from Brazil’s ANVISA for its generic semaglutide injection, aimed at ...
Novo Nordisk increases its 2026 sales outlook for the third time this year, showcasing growth in Wegovy pill sales and its ...
Sino Biopharmaceutical has partnered with Boehringer Ingelheim in a $7 billion agreement for six preclinical oncology ...
Aurobindo Pharma is strategically expanding its respiratory care segment in the US by launching a generic asthma inhaler, ...
Lupin Pharmaceuticals aims to leverage Bristol Myers Squibb's blood thinner Eliquis (apixaban) to counterbalance the ...
The Union Health Ministry of India is revising microbial contamination thresholds for sterile drugs, aligning them with WHO ...
New research reveals GLP-1 drugs significantly lower the risk of type 2 diabetes and cardiovascular issues compared to ...
The Union Health Ministry of India is stepping up its crackdown on substandard drugs by proposing immediate suspension of ...
The Union Health Ministry of India plans to strengthen drug safety by mandating that manufacturers designate qualified ...
Alembic Pharmaceuticals reported a remarkable 81% year-on-year increase in net profit to ₹335 crore for Q2 2023, driven by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results